Livzon Pharmaceutical Group Inc
SZSE:000513
Livzon Pharmaceutical Group Inc
SZSE:000513
Price:
33.84
CNY
0.09%
Market Cap:
¥30B
Relative Value
The Relative Value of one
Livzon Pharmaceutical Group Inc
stock under the Base Case scenario is
hidden
CNY.
Compared to the current market price of 33.84 CNY,
Livzon Pharmaceutical Group Inc
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Livzon Pharmaceutical Group Inc Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Livzon Pharmaceutical Group Inc Competitors
Livzon Pharmaceutical Group Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Livzon Pharmaceutical Group Inc
SZSE:000513
|
30.1B CNY | 2.5 | 13.9 | 8.5 | 8.5 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
924.3B USD | 14.2 | 44.8 | 30.2 | 32.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
575.3B USD | 6.1 | 21.5 | 14.9 | 18.3 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
281.3B CHF | 4.6 | 30 | 12.7 | 14.8 | |
| CH |
|
Novartis AG
SIX:NOVN
|
240.6B CHF | 5.5 | 22.1 | 13.7 | 17.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
230.1B GBP | 5.3 | 30.2 | 16.7 | 23.5 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
286.9B USD | 4.4 | 15.7 | 9.8 | 11.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 344.9 | 865 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.6 | 10.8 | 8 | 9.3 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.3B USD | 2.4 | 19.5 | 7.5 | 10 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
122.1B USD | 2.5 | 17.3 | 7.3 | 9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
